The effect of zeolite on liver function

Investigating the effect of zeolite supplementation in improving liver function and quality of life in cirrhotic patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240301061137N1

Enrollment

Registered

2024-03-10

Start date

2024-03-10

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cirrhotic. Hepatic sclerosis

Interventions

Intervention 1: Intervention group: Recipient of zeolite supplement 500 mg twice daily after meals. Intervention 2: Intervention group: pelacebo.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Confirmed cirrhosis with laboratory tests, imaging or liver biopsy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
MELD score. Timepoint: before intervention and 3 month later. Method of measurement: formula.;CHILD score. Timepoint: before intervention and 3 month later. Method of measurement: Formula.	—

Secondary

Measure	Time frame
Quality of life. Timepoint: before intervention and 3 month later. Method of measurement: Scoring of quality of life in patients with chronic liver disease scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Kavian

Shahid Beheshti University of Medical Sciences

dr.fatemeh.kvn@gmail.com+98 21 23871

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026